Kiernan A. Seth
Geen lopende functies
Vermogen: 81 829 $ op 30-04-2024
Profiel
Kiernan A.
Seth worked as the Head of the Oncology Business Unit at Eisai, Inc. He then served as the Chief Commercial Officer & Vice President at Lexicon Pharmaceuticals, Inc. from 2021 to 2023.
Dr. Seth completed his undergraduate degree at Norfolk State University, followed by an MBA from St. Joseph's University.
He also obtained a doctorate from Meharry Medical College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-02-2023 | 53 136 ( 0.02% ) | 81 829 $ | 30-04-2024 |
Eerdere bekende functies van Kiernan A. Seth
| Bedrijven | Functie | Einde |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02-11-2023 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Opleiding van Kiernan A. Seth
| Norfolk State University | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
| Meharry Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
